Visceral pain hypersensitivity in functional gastrointestinal disorders

British Medical Bulletin

Volumn 91, Issue 1, 2009, Pages 123-136

  Farmer, A D ^a   Aziz, Q ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Central sensitization; Functional brain imaging; Functional gastrointestinal disorders; Irritable bowel syndrome; Peripheral sensitization; Visceral pain hypersensitivity

Indexed keywords

ION CHANNEL; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; AUTONOMIC NERVOUS SYSTEM; BRAIN CORTEX; CHEMICAL ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DIGESTIVE SYSTEM FUNCTION DISORDER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABLE COLON; NERVE FIBER; NEUROIMAGING; NEUROTRANSMISSION; NOCICEPTIVE RECEPTOR; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SENSORY NERVE; VISCERAL PAIN; VISCERAL PAIN HYPERSENSITIVITY;

ABDOMINAL PAIN; GASTROINTESTINAL DISEASES; HUMANS; HYPERALGESIA; NOCICEPTORS; STRESS, PSYCHOLOGICAL; VISCERAL AFFERENTS;

EID: 69949158160     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldp026     Document Type: Review

References (91)

1. Hobson AR, Aziz Q (2003) Central nervous system processing of human visceral pain in health and disease. News Physiol Sci, 18, 109-114.
2. Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 130, 1377-1390.
3. Chang L, Toner BB, Fukudo S et al. (2006) Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology, 130, 1435-1446.
4. Halpert A, Drossman D (2005) Biopsychosocial issues in irritable bowel syndrome. J Clin Gastroenterol, 39, 665-669.
5. Spiller R, Aziz Q, Creed F et al. (2007) Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut, 56, 1770-1798.
6. Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM., Holtmann G (2008) Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. J Gastroenterol Hepatol, 23, 1137-1143.
7. Chang L (2004) Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther, 20(Suppl. 7), 31-39.
8. Ritchie J (1973) Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut, 14, 125-132.
9. Whitehead WE, Holtkotter B, Enck P et al. (1990) Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology, 98, 1187-1192.
10. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA (1995) Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology, 109, 40-52.
11. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R (1991) Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci, 36, 1249-1254.
12. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG (2000) Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet, 356, 1154-1159.
13. Cook IJ, van Eeden A, Collins SM (1987) Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology, 93, 727-733.
14. Verne GN, Himes NC, Robinson ME et al. (2003) Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain, 103, 99-110.
15. Bouin M, Meunier P, Riberdy-Poitras M, Poitras P (2001) Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition? Dig Dis Sci, 46, 2542-2548.
16. Yu S, Ouyang A (200.9) TRPA1 in Bradykinin-induced mechano- hypersensitivity of vagal C fibers in guinea pig esophagus. Am J Physiol Gastrointest Liver Physiol, 296, G255-G265.
17. Jones RC 3rd, Xu L, Gebhart GF (2005) The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci, 25, 10981-10989.
18. Knowles CH, Aziz Q (2008) Visceral hypersensitivity in non-erosive reflux disease. Gut, 57, 674-683.
19. Winston J, Shenoy M, Medley D, Naniwadekar A, Pasticha PJ (2007) The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology, 132, 615-627.
20. Levine JD, Alessandri-Haber N (2007) TRP channels: targets for the relief of pain. Biochim Biophys Acta, 1772, 989-1003.
21. Holzer P (2004) TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol, 500, 231-241.
22. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S (2008) Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut, 57, 923-929.
23. Gomes RB, Brodskyn C, de Oliveira CI et al. (2002) Seroconversion against lutzomyia longipalpis saliva concurrent with the development of anti-leishmania chagasi delayed-type hypersensitivity. J Infect Dis, 186, 1530-1534.
24. Gunthorpe MJ, Szallasi A (2008) Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des, 14, 32-41.
25. Broad LM, Keding SJ, Blanco MJ (2008) Recent progress in the development of selective TRPV1 antagonists for pain. Curr Top Med Chem, 8, 1431-1441.
26. Brierley SM, Page AJ, Hughes PA et al. (2008) Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology, 134, 2059-2069.
27. Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N (2008) Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology, 135, 937-946, 946 e1-2.
28. Sipe WE, Brierley SM, Martin CM et al. (2008) Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol, 294, G1288-G1298.
29. Cenac N, Andrews CN, Holzhausen M, et al. (2007) Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest, 117, 636-647.
30. Barbara G, Wang B, Stangheilini, V et al. (2007) Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology, 132, 26-37.
31. Toda N, Kishioka S, Hatano Y, Toda H (2009) Modulation of opioid actions by nitric oxide signaling. Anesthesiology, 110, 166-181.
32. Takeuchi K, Yokota A, Tanaka A, Takahira Y (2006) Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Dig Dis Sci, 51, 1250-1259.
33. Shamshiri H, Paragomi P, Paydar MJ et al. (2009) Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway. J Gastroenterol Hepatol, 24, 672-680.
34. McKeown ES, Parry SD, Stansfield R, Barton JR, Welfare MR (2006) Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection, Neurogastroenterol Motil, 18, 839-843.
35. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW (2008) The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol, 23, 1689-1694.
36. Piche T, Saint-Paul MC, Dainese R et al. (2008) Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut, 57, 468-473.
37. Ohashi K, Sato Y, Kawai M, Kurebayashi. Y (2008) Abolishment of TNBS-induced visceral, hypersensitivity in mast cell deficient rats. Life Sci, 82, 419-423.
38. Ohashi K, Sato Y, Iwata H, Kawai M, Kurebayashi Y (2007) Colonic mast cell infiltration in rats with TNBS-induced visceral hypersensitivity. J Vet Med Sci, 69, 1223-1228.
39. Leri O, Tubili S, De Rosa FG et al. (1997) Management of diarrhoeic type of irritable bowel syndrome with exclusion diet and disodium cromoglycate. Inflammopharmacology, 5, 153-158.
40. Grundy D (2008) 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions. Eur Rev Med Pharmacol Sci, 12(Suppl. 1), 63-67.
41. Friedel D, Thomas R, Fisher RS (2001) Ischemic colitis during treatment with alosetron, Gastroenterology, 120, 557-560.
42. Schiller LR, Johnson DA (2008) Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care. Am J Gastroenterol, 103, 815-819.
43. Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG (2008) Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome. Am J Gastroenterol, 103, 2562-2569.
44. Cummins TR, Sheets PL, Waxman SG (2007) The roles of sodium channels in nociception: implications for mechanisms of pain. Pain, 131, 243-257.
45. Anand P, Aziz Q, Willert R, van Oudenhove L (2007) Peripheral and central mechanisms of visceral sensitization in man Neurogastroenterol Motil, 19, 29-46.
46. Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson, DG, Aziz Q (2001) Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol, 281, G1196-G1202.
47. Grundy D, Al-Chaer ED, Aziz Q et al. (2006) Fundamentals of neurogastroenterology: basic science. Gastroenterology, 130, 1391-1411.
48. Sarkar S, Hobson, AR, Hughes A et al. (2003) The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology, 124, 18-25.
49. Willert RP, Woolf CJ, Hobson AR, Delaney C, Thompson DG, Aziz Q (2004) The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology, 126, 683-692.
50. Hobson AR, Khan RW, Sarkar S, Furlong PL, Aziz Q (2004) Development of esophageal hypersensitivity following experimental duodenal acidification. Am J Gastroenterol, 99, 813-820.
51. Ness TJ, Metcalf AM, Gebhart GF (1990) A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain, 43, 377-386.
52. Munakata J, Naliboff B, Harraf F et al. (1997) Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology, 112, 55-63.
53. Hobson AR, Aziz Q (2004) Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut, 53, 1198-1206.
54. Sharma A, Lelic D, Brock C, Paine P, Aziz Q (2009) New technologies to investigate the brain-gut axis. World J Gastroenterol, 15, 182-191.
55. Mayer EA (2000) Spinal and supraspinal modulation of visceral sensation, Gut, 47(Suppl. 4), iv69-iv72, discussion iv76.
56. Chang L, Berman S, Mayer EA et al. (2003) Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol, 98, 1354-1361.
57. Coen SJ, Aziz Q, Yaguez L, Brammer M, Williams SC, Gregory LJ (2008) Effects of attention on visceral stimulus intensity encoding in the male human brain, Gastroenterology, 135, 2065-2074, 2074 e1.
58. Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD (2005) Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut, 54, 1396-1401.
59. Staud R, Rodriguez ME (2006) Mechanisms of disease: pain in fibromyalgia syndrome. Nat Clin Praet Rheumatol, 2, 90-98.
60. Lee CT, Chuang TY, Lu CL, Chen CY, Chang FY, Lee SD (1998) Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospitalbased oriental study. Dig Dis Sci, 43, 1794-1799.
61. Tousignant-Laflamme Y, Goffaux P, Bourgault P, Marchand S (2006) Different autonomic responses to experimental pain in IBS patients and healthy controls. J Clin Gastroenterol, 40, 814-820.
62. Aggarwal A, Cutts TF, Abell TL et al. (1994) Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology, 106, 945-950.
63. Heitkemper M., Jarrett M, Cain KC et al. (2001) Autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci, 46, 1276-1284.
64. Gupta V, Sheffield D, Verne GN (2002) Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig Dis Sci, 47, 1716-1722.
65. Waring WS, Chui M, Japp A, Nicol EF, Ford MJ (2004) Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol, 38, 658-663.
66. Emmanuel AV, Kamm MA (2000) Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut, 46, 212-217.
67. Thoua NM, Murray CD, Winchester WJ et al. (2009) Amitriptyline modifies the visceral hypersensitivity response to acute stress in irritable bowel syndrome. Aliment Pharmacol Ther, 29, 552-560.
68. Mazur M, Furgala A, Jablonski K et al. (2007) Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients. J Physiol Pharmacol, 58(Suppl. 3), 131-139.
69. Spaziani R, Bayati A, Redmond K et al. (2008) Vagal dysfunction in irritable bowel syndrome assessed by rectal distension and baroreceptor sensitivity. Neurogastroenterol Motil, 20, 336-342.
70. Pickering AE, Boscan P, Paton JF (2003) Nociception attenuates parasympathetic but not sympathetic baroreflex via NK1 receptors in the rat nucleus tractus solitarii, J Physiol, 551, 589-599.
71. Maixner W, Randich A (1984) Role of the right vagal nerve trunk in antinociception. Brain Res, 298, 374-377.
72. Tyler K, Moriceau S, Sullivan RM, Greenwood-Van Meerveld B (2007) Long-term colonic hypersensitivity in adult rats induced by neonatal unpredictable vs predictable shock. Neurogastroenterol Motil, 19, 761-768.
73. Leserman J, Drossman DA (2007) Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms. Trauma Violence Abuse, 8, 331-343.
74. Barreau F, Ferner L, Fioramonti J, Bueno L (2007) New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr Res, 62, 240-245.
75. Alander T, Heimer G, Svardsudd K, Agreus L (2008) Abuse in women and men with and without functional gastrointestinal disorders. Dig Dis Sci, 53, 1856-1864.
76. Gwee KA, Leong YL, Graham C et al. (1999) The role of psychological and biological factors in postinfective gut dysfunction. Gut, 44, 400-406.
77. Palsson OS, Drossman DA (2005) Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological, treatments. Gastroenterol Clin North Am, 34, 281-303.
78. Saito YA, Zimmerman JM, Harmsen WS et al. (2008) Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil, 20, 790-797.
79. Saito YA, Talley NJ (2008) Genetics of irritable bowel syndrome. Am J Gastroenterol, 103, 2100-2104, quiz 2105.
80. Camilleri M, Busciglio I, Carlson P et al. (2008) Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol, 295, G219-G225.
81. Jones MP, Dilley JB, Drossman D, Crowell MD (2006) Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil, 18, 91-103.
82. Ohman L, Simren M (2007) New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis, 39, 201-215.
83. Drossman DA (2005) What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders? J Clin Gastroenterol, 39, S251-S256.
84. Wingenfeld K, Heim C, Schmidt I, Wagner D, Meinlschmidt G, Hellhammer DH (2008) HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psyehosom Med, 70, 65-72.
85. Dinan TG, Quigley EM, Ahmed SM et al. (2006) Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology, 130, 304-311.
86. Koch A, Zacharowski K, Boehm. O et al. (2007) Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res, 56, 32-37.
87. La JH, Sung TS, Kim HJ, Kim TW, Kang TM, Yang IS (2008) Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats. World J Gastroenterol, 14, 731-736.
88. Nozu T, Kudaira M (2006) Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans. J Gastroenterol, 41, 740-744.
89. Larauche M, Bradesi S, Million M et al. (2008) Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am J Physiol Gastrointest Liver Physiol, 294, G1033-G1040.
90. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA (2005) Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil, 17, 415-422.
91. Martinez V, Tache Y (2006) CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des, 12, 4071-4088.